SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-025781
Filing Date
2019-02-01
Accepted
2019-02-01 15:19:33
Documents
7
Period of Report
2019-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d699104d8k.htm 8-K 24570
2 EX-1.1 d699104dex11.htm EX-1.1 163915
3 EX-4.1 d699104dex41.htm EX-4.1 96534
4 EX-5.1 d699104dex51.htm EX-5.1 7818
5 EX-99.1 d699104dex991.htm EX-99.1 9062
6 EX-99.2 d699104dex992.htm EX-99.2 9068
7 EX-99.3 d699104dex993.htm EX-99.3 8760
  Complete submission text file 0001193125-19-025781.txt   321030
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 19559571
SIC: 2834 Pharmaceutical Preparations